Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Apathy in Alzheimer's Dementia
NCT00495820Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in apathy, sponsored by VA Office of Research & Development. Started Aug 2007; status: completed.
02
Drugs
methylphenidate
03
Conditions
apathy
Beyond the preview
Go deeper on NCT00495820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495820.